Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in moderate Parkinson's disease
2009-018137-37Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of exenatide in Parkinson's disease (PD) (2 arms), sponsored by University College London. Primary endpoint: Change in UPDRS off-medication motor subscore. Started Mar 2010; status: completed.
02
Drugs
exenatide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2009-018137-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018137-37.